HCPCS drug code · CMS crosswalk
Carboplatin J-Code / HCPCS Code
In short
Carboplatin is billed under HCPCS J9045 — Injection, carboplatin, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 27 Carboplatin NDCs under this code.
Reference
- J9045
- Injection, carboplatin, 50 mgBilling unit: 50 mg
- Labelers
- Accord Healthcare Inc; Apotex Corp; Eugia US LLC; FreseniUS Kabi USA, LLC; Pfizer Inc; Teva Parenteral Medicines, Inc.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Carboplatin units and claim line
Enter the dose given to get the J9045 units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
Carboplatin NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00703-4239-01 | J9045 | Teva Parenteral Medicines, Inc. | 60 | 12 |
| 00703-4239-81 | J9045 | Teva Parenteral Medicines, Inc. | 60 | 12 |
| 00703-4244-01 | J9045 | Teva Parenteral Medicines, Inc. | 5 | 1 |
| 00703-4244-81 | J9045 | Teva Parenteral Medicines, Inc. | 5 | 1 |
| 00703-4246-01 | J9045 | Teva Parenteral Medicines, Inc. | 15 | 3 |
| 00703-4246-81 | J9045 | Teva Parenteral Medicines, Inc. | 15 | 3 |
| 00703-4248-01 | J9045 | Teva Parenteral Medicines, Inc. | 45 | 9 |
| 00703-4248-81 | J9045 | Teva Parenteral Medicines, Inc. | 45 | 9 |
| 16729-0295-12 | J9045 | Accord Healthcare Inc | 60 | 12 |
| 16729-0295-34 | J9045 | Accord Healthcare Inc | 45 | 9 |
| 55150-0335-00 | J9045 | Eugia US LLC | 45 | 9 |
| 55150-0335-01 | J9045 | Eugia US LLC | 45 | 9 |
| 55150-0386-00 | J9045 | Eugia US LLC | 60 | 12 |
| 55150-0386-01 | J9045 | Eugia US LLC | 60 | 12 |
| 60505-6282-01 | J9045 | Apotex Corp | 5 | 1 |
| 60505-6282-03 | J9045 | Apotex Corp | 15 | 3 |
| 60505-6282-06 | J9045 | Apotex Corp | 45 | 9 |
| 60505-6282-07 | J9045 | Apotex Corp | 60 | 12 |
| 61703-0150-05 | J9045 | Pfizer Inc | 15 | 3 |
| 61703-0262-05 | J9045 | Pfizer Inc | 45 | 9 |
| 61703-0339-18 | J9045 | Pfizer Inc | 5 | 1 |
| 61703-0339-22 | J9045 | Pfizer Inc | 15 | 3 |
| 61703-0339-50 | J9045 | Pfizer Inc | 45 | 9 |
| 61703-0339-56 | J9045 | Pfizer Inc | 45 | 12 |
| 61703-0360-18 | J9045 | Pfizer Inc | 5 | 1 |
| 61703-0600-05 | J9045 | Pfizer Inc | 60 | 12 |
| 63323-0172-60 | J9045 | FreseniUS Kabi USA, LLC | 60 | 12 |
Carboplatin: common questions
- What is the J-code for Carboplatin?
- Carboplatin is billed under HCPCS J9045 — Injection, carboplatin, 50 mg. One billing unit is 50 mg. CMS's crosswalk lists 27 Carboplatin NDCs under this code.
- How many J9045 billing units are in a package of Carboplatin?
- CMS lists 1 to 12 billing units per package, depending on the NDC, where one unit is 50 mg. Units to report are based on the dose given, not the package.
- Is J9045 a CPT code?
- No. J9045 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.